Clinical trials
Phase 3 Neuroblastoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Terminated | 3 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Oncology Group | 9 |
| Fred Hutchinson Cancer Center | 3 |
| National Cancer Institute (NCI) | 2 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| GE Healthcare | 1 |
| Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Northwestern University | 1 |
| OHSU Knight Cancer Institute | 1 |
| Tufts Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuroblastoma | 22 |
| Testicular Neoplasms | 8 |
| Blast Crisis | 7 |
| Burkitt Lymphoma | 7 |
| Leukemia, Myeloid, Accelerated Phase | 7 |
| Leukemia, Myeloid, Chronic-Phase | 7 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 7 |
| Primary Myelofibrosis | 7 |
| Wilms Tumor | 7 |
| Breast Neoplasms | 6 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.